Building reliable local medicine production for Ethiopia.
MPM PLC is developing a 52,200 sqm pharmaceutical manufacturing facility in Bahirdar, designed for essential medicines, specialized antibiotic production, and sterile formats.
Facility Overview
MPM Bahirdar Manufacturing Campus
Block 01
General Block
Oral solid dosage
Block 02
Beta-Lactam Block
Penicillin antibiotics
Block 03
Cephalosporin Block
Cephalosporin antibiotics
Block 04
Sterile & Injectable Block
Vials, ampoules, sterile formats
0, sqm
facility
Bahirdar, Amhara Region
0+
products
Across eight dosage forms
0
specialized blocks
Dedicated production environments
0
established
Built for import substitution
Operational readiness
A purpose-built platform for local pharmaceutical supply.
The homepage now leads with the facts partners and institutional buyers need: scale, portfolio breadth, dedicated manufacturing environments, and compliance-minded facility planning.
Site
Bahirdar, Amhara Region
Strategically located for national supply and regional export corridors.
Portfolio
Essential medicines first
Tablets, capsules, injectables, drops, creams, suppositories, suspensions, and IV infusions.
Standards
Designed for compliance
Facility planning aligned with WHO GMP, PIC/S, and EFDA expectations.
Manufacturing capabilities
Four dedicated blocks for focused pharmaceutical production.
Each production environment is structured around clear dosage forms, containment needs, and quality controls, making the capability story easier for partners to evaluate.
General Block
Oral solid dosage
4B tablets and 200M capsules/year
High-speed compression, encapsulation, coating, blister packaging, and cartoning for essential medicines.
Beta-Lactam Block
Penicillin antibiotics
1.8B tablets and 60M capsules/year
Dedicated HVAC, pressure cascades, personnel airlocks, and material flows for isolated beta-lactam production.
Cephalosporin Block
Cephalosporin antibiotics
500M tablets and 60M capsules/year
Self-contained utilities and containment systems designed to prevent cross-contamination across product families.
Sterile & Injectable Block
Vials, ampoules, sterile formats
150M vials and 50M ampoules/year
Aseptic filling lines, environmental monitoring, and sterile processing workflows for critical care products.
Purpose
Strengthening healthcare sovereignty through local production.
MPM PLC is positioned around a practical mandate: produce high-quality, affordable medicines in Ethiopia while reducing dependency on imported supply.
Mission
Manufacture high-quality, affordable pharmaceutical products in Ethiopia and support reliable access to essential medicines.
Vision
Become a leading African pharmaceutical manufacturer recognized for quality, accessibility, and dependable regional supply.
Market strategy
Serving Ethiopia first, then scaling across East Africa.
The business case is simple: build local supply resilience, preserve foreign currency, and create a manufacturing base that can serve neighboring markets.
$20M+
Domestic market opportunity
Focused on replacing imported essential medicines with reliable Ethiopian production capacity.
$10M+
Regional export opportunity
Positioned for corridors into Djibouti, Somalia, South Sudan, Kenya, and Sudan.
Partnership
Start a conversation about reliable pharmaceutical supply.
Connect with MPM PLC for distribution, procurement, investment, and export partnership opportunities.
Partnership areas